INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $43,605 | -74.8% | 13,500 | -89.6% | 0.00% | -100.0% |
| Q2 2016 | $173,000 | -74.7% | 130,000 | 0.0% | 0.00% | -75.0% |
| Q1 2016 | $685,000 | +22733.3% | 130,000 | +48407.5% | 0.00% | – |
| Q2 2015 | $3,000 | -98.7% | 268 | -98.1% | 0.00% | -100.0% |
| Q4 2014 | $233,000 | -80.4% | 13,804 | -84.0% | 0.00% | -87.5% |
| Q4 2013 | $1,191,000 | -58.5% | 86,295 | -47.5% | 0.01% | -71.4% |
| Q3 2013 | $2,867,000 | -38.1% | 164,521 | -42.5% | 0.03% | -44.0% |
| Q2 2013 | $4,629,000 | – | 285,885 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |